Surveillance strategies in inflammatory bowel disease

Minerva Gastroenterologica e Dietologica

Volumn 56, Issue 2, 2010, Pages 189-201

  Schmidt, C ^a   Bielecki, C ^a   Felber, J ^a   Stallmach, A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Colitis, ulcerative; Crohn disease; Endoscopy; Gastrointestinal neoplasms

Indexed keywords

AMINOLEVULINIC ACID;

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RISK; CHROMOENDOSCOPY; CLINICAL TRIAL; COLON BIOPSY; COLONOSCOPY; COLORECTAL CANCER; CONFOCAL LASER MICROSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; FLUORESCENCE IMAGING; HIGH RISK POPULATION; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK REDUCTION; ULCERATIVE COLITIS;

BIOPSY; COLITIS, ULCERATIVE; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; INFLAMMATORY BOWEL DISEASES; MICROSCOPY, CONFOCAL; POPULATION SURVEILLANCE; RISK; TIME FACTORS;

EID: 77954730505     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Yoemans FC. Carcinomatous degeneration of rectal adenomas: Report of seven cases. JAMA 1927;89:852-5.
2. Bargen JA. Chronic ulcerative colitis associated with malignant metaplasia. Arch Surg 1928;17:561.
3. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35.
4. Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006;130:1030-8.
5. Jess T, Loftus EV Jr, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroentero-logy 2006;130:1039-46.
6. Jess T, Gamborg M, Matzen P, Munkholm P, Sørensen TI. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005;100:2724-9.
7. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990;323:1228-33. (Pubitemid 20366527)
8. Heuschen UA, Hinz U, Allemeyer EH, Stern J, Lucas M, Autschbach F et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 2001;120:841-7. (Pubitemid 32193181)
9. Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 2002;56:48-54.
10. Askling J, Dickman PW, Karlén P, Broström O, Lapidus A, Löfberg R et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001;120:1356-62. (Pubitemid 32322309)
11. Askling J, Dickman PW, Karlén P, Broström O, Lapidus A, Löfberg R et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet 2001;357:262-6. (Pubitemid 32120857)
12. Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-9. (Pubitemid 38182302)
13. Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007;133:1099-105. (Pubitemid 47494461)
14. Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004;53:1813-6. (Pubitemid 39556902)
15. Rubio CA, Befrits R, Ljung T, Jaramillo E, Slezak P. Colorectal carcinoma in ulcerative colitis is decreasing in Scandinavian countries. Anticancer Res 2001;21(4B):2921-4. (Pubitemid 33051152)
16. Itzkowitz SH, Present DH. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:314-21.
17. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990;336:357-9. (Pubitemid 20264156)
18. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006;23:1097-104. (Pubitemid 43779348)
19. Sachar DB. Cancer in Crohn's disease: dispelling the myths. Gut 1994;35:1507-8.
20. Xie J, Itzkowitz SH. Cancer in inflammatory bowel disease. World J Gastroenterol 2008;14:378-89. (Pubitemid 351320846)
21. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet 2001;10:721-33.
22. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997;275):1787-90. (Pubitemid 27136715)
23. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004;126:1634-48. (Pubitemid 38649879)
24. Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Nagayasu T et al. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors. J Clin Pathol 2005;58:833-8. (Pubitemid 41113390)
25. Atreya R, Neurath MF. Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Curr Drug Targets 2008;9:369-74. (Pubitemid 352025210)
26. Carey R, Jurickova I, Ballard E, Bonkowski E, Han X, Xu H et al. Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease. Inflamm Bowel Dis 2008;14:446-57. (Pubitemid 351571824)
27. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431:461-6. (Pubitemid 39329586)
28. Lutgens MW, Vleggaar FP, Schipper ME, Stokkers PC, van der Woude CJ, Hommes DW et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut 2008;57:1246-51.
29. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002;51(Suppl 5):V10-V2.
30. Woolrich AJ, DaSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology 1992;103:431-8.
31. Kaltz B, Bokemeyer B, Hoffmann J, Porschen R, Rogler G, Schmiegel W. [Surveillance colonoscopy in ulcerative colitis patients in Germany]. Z Gastroenterol 2007;45:325-31.
32. Rubin CE, Haggitt RC, Burmer GC, Brentnall TA, Stevens AC, Levine DS et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-20.
33. Taylor BA, Pemberton JH, Carpenter HA, Levin KE, Schroeder KW, Welling DR et al. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum 1992;35:950-6.
34. Blonski W, Kundu R, Lewis J, Aberra F, Osterman M, Lichtenstein GR. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis? Scand J Gastroenterol 2008;43:698-703.
35. Kiesslich R, Fritsch J, Holtmann M, Koehler HH, Stolte M, Kanzler S et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880-8. (Pubitemid 36389789)
36. Sada M, Igarashi M, Yoshizawa S, Kobayashi K, Katsumata T, Saigenji K et al. Dye spraying and magnifying endoscopy for dysplasia and cancer surveillance in ulcerative colitis. Dis Colon Rectum 2004;47:1816-23. (Pubitemid 40064424)
37. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004;53:256-60. (Pubitemid 38125515)
38. Toruner M, Harewood GC, Loftus EV Jr, Sandborn WJ, Tremaine WJ, Faubion WA et al. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease. Inflamm Bowel Dis 2005;11:428-34. (Pubitemid 40704076)
39. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006;355:2533-41.
40. Thomas-Gibson S, Rogers P, Cooper S, Man R, Rutter MD, Suzuki N et al. Judgement of the quality of bowel preparation at screening flexible sigmoidoscopy is associated with variability in adenoma detection rates. Endoscopy 2006;38:456-60. (Pubitemid 43744702)
41. Sachar DB. Cancer in Crohn's disease: dispelling the myths. Gut 1994;35:1507-8.
42. Friedman S, Rubin PH, Bodian C, Goldstein E, Harpaz N, Present DH. Screening and surveillance colonoscopy in chronic Crohn's colitis. Gastroenterology 2001;120:820-6. (Pubitemid 32193178)
43. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 2003;124:544-60.
44. Saunders BP, Brown GJ, Lemann M, Rutgeerts P. Balloon dilation of ileocolonic strictures in Crohn's disease. Endoscopy 2004;36:1001-7. (Pubitemid 39485301)
45. Yamazaki Y, Ribeiro MB, Sachar DB, Aufses AH Jr, Greenstein AJ. Malignant colorectal strictures in Crohn's disease. Am J Gastroenterol 1991;86:882-5.
46. Connell WR, Sheffield JP, Kamm MA, Ritchie JK, Hawley PR, Lennard-Jones JE. Lower gastrointestinal malignancy in Crohn's disease. Gut 1994;35):347-52.
47. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
48. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
49. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5.
50. Kuismanen SA, Holmberg MT, Salovaara R, de la Chapelle A, Peltomäki P. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol 2000;156:1773-9. (Pubitemid 30646714)
51. Bernstein CN, Weinstein WM, Levine DS, Shanahan F. Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol 1995;90:2106-14.
52. Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993;105:418-24.
53. Lynch DA, Lobo AJ, Sobala GM, Dixon MF, Axon AT. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34:1075-80.
54. Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc 2007;65:998-1004.
55. Rex DK, Helbig CC. High yields of small and flat adenomas with high-definition colonoscopes using either white light or narrow band imaging. Gastroenterology 2007;133:42-7.
56. Hurlstone DP, Sanders DS, Lobo AJ, McAlindon ME, Cross SS. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy 2005;37:1186-92.
57. Marion JF, Waye JD, Present DH, Israel Y, Bodian C, Harpaz N et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008;103:2342-9.
58. Kudo S, Rubio CA, Teixeira CR, Kashida H, Kogure E. Pit pattern in colorectal neoplasia: endoscopic magnifying view. Endoscopy 201;33:367-73.
59. Adler A,Pohl H,Papanikolaou IS, Abou-Rebyeh H, Schachschal G, Veltzke-Schlieker W et al. A randomised study on narrow-band imaging versus conventional colonoscopy for adenoma detection: does narrow-band imaginginduce a learning effect? Gut 200;57:59-64.
60. Dekker E, van den Broek FJ, Reitsma JB, Hardwick JC, Offerhaus GJ, van Deventer SJ et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007;39:216-21. (Pubitemid 46510792)
61. Matsumoto T, Kudo T, Jo Y, Esaki M, Yao T, Iida M. Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study. Gastrointest Endosc 2007;66:957-65. (Pubitemid 47600174)
62. Messmann H, Endlicher E, Freunek G, Rümmele P, Schölmerich J, Knüchel R. Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic acid sensitisation. Gut 2003;52:1003-7. (Pubitemid 36765293)
63. Kiesslich R, Neurath MF. What new endoscopic imaging modalities will become important in the diagnosis of IBD? Inflamm Bowel Dis 2008;14(Suppl 2):S172-S6.
64. Kiesslich R, Burg J, Vieth M, Gnaendiger J, Enders M, Delaney P et al. Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology 2004;127:706-13.
65. Kiesslich R, Goetz M, Lammersdorf K, hneider C, Burg J, Stolte M et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 2007;132:874-82.
66. Chiu HM, Chang CY, Chen CC, Lee YC, Wu MS, Lin JT et al. A prospective comparative study of narrow-band imaging, chromoendoscopy, and conventional colonoscopy in the diagnosis of colorectal neoplasia. Gut 2007;56:373-9.
67. East JE, Suzuki N, von Herbay A, Saunders BP. Narrow band imaging with magnification for dysplasia detection and pit pattern assessment in ulcerative colitis surveillance: a case with multiple dysplasia associated lesions or masses. Gut 2006;55:1432-5. (Pubitemid 44476787)
68. Ochsenkühn T, Tillack C, Stepp H, Diebold J, Ott SJ, Baumgartner R et al. Low frequency of colorectal dysplasia in patients with long-standing inflammatory bowel disease colitis: detection by fluorescence endoscopy. Endoscopy 2006;38:477-82. (Pubitemid 43744705)
69. van den Broek FJ, Fockens P, van Eeden S, Reitsma JB, Hardwick JC, Stokkers PC et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut 2008;57:1083-9.
70. hen B, Zuccaro G Jr, Gramlich TL, Gladkova N, Trolli P, Kareta M et al. In vivo colonoscopic optical coherence tomography for transmural inflammation in inflammatory bowel disease. Clin Gastroenterol Hepatol 2004;2:1080-7.
71. Consolo P, Strangio G, Luigiano C, Giacobbe G, Pallio S, Familiari L. Optical coherence tomography in inflammatory bowel disease: prospective evaluation of 35 patients. Dis Colon Rectum 2008;51:1374-80.
72. Obrador A, Ginard D, Barranco L. Review article: colorectal cancer surveillance in ulcerative colitis - what should we be doing? Aliment Pharmacol Ther 2006;24(Suppl 3):56-63.
73. Kiesslich R, Neurath MF. Chromoendoscopy and other novel imaging techniques. Gastroenterol Clin North Am 2006;35:605-19. (Pubitemid 44307576)